Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 21Recruiting 12Active not recruiting 6Terminated 4Unknown 3Suspended 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 44Gastrointestinal 6Head & Neck 5Gynecologic 4Genitourinary 4Lymphoid 3Dermatologic 3CNS 3Breast 3Other hematologic neoplasm 2Thoracic 1Plasma cell 1NET 1Endocrine 1Classical hematology 1

Conditions

Thyroid Cancer, Papillary 15Neuroendocrine Tumors 13Carcinoma, Neuroendocrine 10Pituitary Neoplasms 8Thyroid Neoplasms 6Thyroid Carcinoma, Anaplastic 5Pheochromocytoma 5Neoplasms 4Paraganglioma 3Multiple Endocrine Neoplasia Type 1 3Small Cell Lung Carcinoma 2Recurrence 2Rectal Neuroendocrine Tumor 2Pituitary ACTH Hypersecretion 2Neoplasm Metastasis 2Melanoma 2Cushing Syndrome 2Adenocarcinoma, Follicular 2Acromegaly 2Uterine Cervical Neoplasms 1Urinary Tract Infections 1Thyroid cancer, medullary 1Testicular Neoplasms 1Serotonin Syndrome 1Sarcoma 1SDH-Related Familial Paraganglioma 1Rectal Neuroendocrine Tumors 1Rectal Neoplasms 1Prostatitis 1Prostatic Neoplasms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Sarcoma × Endocrine × Clear all
NCT04889742 2023-12-26

HETERERO

Charite University, Berlin, Germany

Phase 2 Not yet recruiting
110 enrolled
EndocrineGastrointestinalGenitourinaryGynecologicNETSarcoma

Hyperthermia, Anus Neoplasms, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Fever, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Recurrence, Sarcoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡